Neuprozin mito
Asset
Fixed combination of citicoline, nicotinamide, PQQ, and homotaurine to reduce mitochondrial dysfunction and oxidative stress.
- Stage
- Human trials
- Modality
- Supplement
- Target
- Oxidative stress and ROS signalling
- 1
- Indication
- 1
- Trial
- 1
- Developer
Indications
1Glaucoma
Human trials, Completed, NCT07861243, clinicaltrials.gov, 7 Oct 2026
In the full profile
- Targets and what it contains2
- Owner and partners1
- Trials1
- Evidence for its targets2
- Competitors1
- Aging relevance1
- Signals1
Every asset’s record: target, stage, trials and the evidence behind it.